Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 137231, 7 pages
http://dx.doi.org/10.1155/2014/137231
Research Article

The Association among Antioxidant Enzymes, Autoantibodies, and Disease Severity Score in Systemic Lupus Erythematosus: Comparison of Neuropsychiatric and Nonneuropsychiatric Groups

1Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
2Department of Biological Science, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan
3Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
4Department of Emergency Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
5Department of Radiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan

Received 25 February 2014; Accepted 1 April 2014; Published 27 April 2014

Academic Editor: Hung-Chen Wang

Copyright © 2014 Yu-Jih Su et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Ollier, E. Davies, N. Snowden et al., “Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro+/La- autoantibody profile in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 39, no. 10, pp. 1763–1764, 1996. View at Google Scholar · View at Scopus
  2. C. Kiyohara, M. Washio, T. Horiuchi et al., “Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population,” Scandinavian Journal of Rheumatology, vol. 41, no. 2, pp. 103–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. I. K. Mohan and U. N. Das, “Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 56, no. 3, pp. 193–198, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. P. E. Morgan, A. D. Sturgess, and M. J. Davies, “Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 52, no. 7, pp. 2069–2079, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. Evans, M. S. Cooke, M. Akil, A. Samanta, and J. Lunec, “Aberrant processing of oxidative DNA damage in systemic lupus erythematosus,” Biochemical and Biophysical Research Communications, vol. 273, no. 3, pp. 894–898, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. E. L. Smith and R. H. Shmerling, “The American college of rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement,” Lupus, vol. 8, no. 8, pp. 586–595, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. D. D. Gladman, D. Ibañez, and M. B. Urowltz, “Systemic lupus erythematosus disease activity index 2000,” Journal of Rheumatology, vol. 29, no. 2, pp. 288–291, 2002. View at Google Scholar · View at Scopus
  8. J. G. Hanly, “ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables,” Lupus, vol. 13, no. 11, pp. 861–864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. McCord and I. Fridovich, “Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein),” The Journal of Biological Chemistry, vol. 244, no. 22, pp. 6049–6055, 1969. View at Google Scholar · View at Scopus
  10. I. Avalos, C. P. Chung, A. Oeser et al., “Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms,” Lupus, vol. 16, no. 3, pp. 195–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. R. J. Ames, J. Alves, I. Murat, D. A. Isenberg, and J. Nourooz-Zadeh, “Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement,” Rheumatology, vol. 38, no. 6, pp. 529–534, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Kovacic and J. D. Jacintho, “Systemic lupus erythematosus and other autoimmune diseases from endogenous and exogenous agents: unifying theme of oxidative stress,” Mini Reviews in Medicinal Chemistry, vol. 3, no. 6, pp. 568–575, 2003. View at Google Scholar · View at Scopus
  13. A. Perl, “Oxidative stress in the pathology and treatment of systemic lupus erythematosus,” Nature Reviews Rheumatology, vol. 9, no. 674, p. 686, 2013. View at Publisher · View at Google Scholar
  14. J. D. Alves and P. R. J. Ames, “Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome,” Immunobiology, vol. 207, no. 1, pp. 23–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Matsuura, K. Kobayashi, and L. R. Lopez, “Atherosclerosis in autoimmune diseases,” Current Rheumatology Reports, vol. 11, no. 1, pp. 61–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lozovoy, A. Simao, S. Oliveira et al., “Relationship between iron metabolism, oxidative stress, and insulin resistance in patients with systemic lupus erythematosus,” Scandinavian Journal of Rheumatology, vol. 42, no. 4, pp. 303–310, 2013. View at Publisher · View at Google Scholar
  17. S. S. Koca, I. Karaca, M. F. Yavuzkir et al., “Insulin resistance is related with oxidative stress in systemic lupus erythematosus,” The Anatolian Journal of Cardiology, vol. 9, no. 1, pp. 23–28, 2009. View at Google Scholar · View at Scopus
  18. M. J. Ryan, “The pathophysiology of hypertension in systemic lupus erythematosus,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 296, no. 4, pp. R1258–R1267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. W. Mathis, M. Venegas-Pont, C. W. Masterson, N. J. Stewart, K. L. Wasson, and M. J. Ryan, “Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus,” Hypertension, vol. 59, no. 3, pp. 673–679, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Lozovoy, A. Simão, C. Panis et al., “Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus,” Lupus, vol. 20, no. 12, pp. 1250–1259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Tewthanom, S. Janwityanuchit, K. Totemchockchyakarn, and D. Panomvana, “Correlation of lipid peroxidation and glutathione levels with severity of systemic lupus erythematosus: a pilot study from single center,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 11, no. 3, pp. 30–34, 2008. View at Google Scholar · View at Scopus
  22. F. I. Romero, M. A. Khamashta, and G. R. V. Hughes, “Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis,” Lupus, vol. 9, no. 3, pp. 206–209, 2000. View at Google Scholar · View at Scopus
  23. E. Matsuura, K. Kobayashi, T. Yasuda, and T. Koike, “Antiphospholipid antibodies and atherosclerosis,” Lupus, vol. 7, supplement 2, pp. S135–S139, 1998. View at Google Scholar · View at Scopus
  24. T. Ilić, S. Curić, S. Vodopivec et al., “Anti-U1RNP antibodies and lupus nephritis,” Medicinski Pregled, vol. 53, no. 11-12, pp. 589–594, 2000. View at Google Scholar · View at Scopus
  25. D. Carmona-Fernandes, M. J. Santos, H. Canhao, and J. E. Fonseca, “Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile,” BMC Medicine, vol. 11, article 98, 2013. View at Publisher · View at Google Scholar
  26. S. Madrane and C. Ribi, “Central neuropsychiatric involvement in systemic lupus erythematosus,” Revue Médicale Suisse, vol. 8, no. 337, pp. 848–853, 2012. View at Google Scholar
  27. G. K. Bertsias, J. P. A. Ioannidis, M. Aringer et al., “EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs,” Annals of the Rheumatic Diseases, vol. 69, no. 12, pp. 2074–2082, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Govoni, S. Bombardieri, A. Bortoluzzi et al., “Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 italian patients,” Rheumatology, vol. 51, no. 1, Article ID ker310, pp. 157–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. R. M. Pereira, N. H. Yoshinari, R. M. de Oliveira, and W. Cossermelli, “Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus,” Lupus, vol. 1, no. 3, pp. 175–179, 1992. View at Google Scholar · View at Scopus
  30. J. G. Hanly, M. B. Urowitz, L. Su et al., “Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 70, no. 10, pp. 1726–1732, 2011. View at Publisher · View at Google Scholar
  31. Y. Yoshikawa, H. Mizutani, and M. Shimizu, “Systemic lupus erythematosus with ischemic peripheral neuropathy and lupus anticoagulant: response to intravenous prostaglandin E1,” Cutis, vol. 58, no. 6, pp. 393–396, 1996. View at Google Scholar · View at Scopus
  32. Y. P. Guo, “Sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus,” Chinese Journal of Neurology and Psychiatry, vol. 22, no. 3, pp. 163–191, 1989. View at Google Scholar · View at Scopus
  33. P. A. McCombe, J. G. McLeod, J. D. Pollard, Y. P. Guo, and T. J. Ingall, “Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Clinical, pathological and immunological features,” Brain, vol. 110, part 2, pp. 533–549, 1987. View at Google Scholar · View at Scopus